The Maharashtra Food and Drug Administration (FDA) orders the closure of 10 Ayurvedic manufacturers, including Krishna Herbal and Yashoda Labs, according to NDTV. The action follows regulatory inspections and enforcement aimed at manufacturers that are accused of not meeting required quality and safety standards.
The FDA’s stated basis for shutting the companies is non-compliance with mandatory standards. The firms are described as being targeted for alleged failures related to quality assurance and safety requirements under applicable regulations. The reports collectively frame the move as part of broader enforcement to ensure Ayurvedic products and manufacturing practices comply with legal expectations.
While the outlets agree on the closures and the overall regulatory rationale, the available information focuses mainly on the enforcement outcome and the compliance concerns cited by the FDA. Details such as specific products affected, the timelines of inspections, and whether corrective actions are permitted are not specified in the provided excerpts.
